Interactions between iboga agents and methamphetamine sensitization: Studies of locomotion and stereotypy in rats

Psychopharmacology

Volumn 151, Issue 2-3, 2000, Pages 234-241

  Szumlinski, K K ^a   Balogun, M Y ^b   Maisonneuve, I M ^a   Glick, S D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

18 Methoxycoronaridine; Ibogaine; Locomotor activity; Methamphetamine; Sensitization; Stereotypy

Indexed keywords

CENTRAL STIMULANT AGENT; COCAINE; CORONARIDINE; DRUG VEHICLE; IBOGAINE; METHAMPHETAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG POTENCY; DRUG SELF ADMINISTRATION; DRUG SENSITIZATION; FEMALE; LOCOMOTION; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HALLUCINOGENS; IBOGAINE; METHAMPHETAMINE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR;

EID: 0033842634     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000478     Document Type: Article

References (53)

1. The EEG and cocaine sensitization: A hypothesis
2. Psychosis induced by central nervous system stimulants and related drugs
3. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?
4. Ibogaine effects on sweet preference and amphetamine-induced locomotion: Implications for drug addiction
5. Acute effects of cocaine on human brain activity and emotion
6. Inhibitory effects of ibogaine on cocaine self-administration in rats
7. Limbic activation during cue-induced cocaine craving
8. Cocaine
9. Amphetamine response in rat after dopamine neuron destruction
10. Cocaine self-administration increases the incentive motivational properties of the drugs in rats
11. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization
12. Individual differences in acute effects of drugs in humans: Their relevance to risk for abuse
13. Amphetamine psychosis. II. Theoretical implications
14. Reward, motivation, cognition: Psychobiology of mesotelencephalic dopamine systems
15. Changes in amphetamine sensitivity following frontal cortical damage in rats and mice
16. Mechanisms of anti-addictive actions of ibogaine
17. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: Relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum
18. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: Effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats
19. Ibogaine-like effects of noribogaine in rats
20. ±-18-Methoxycoronaridine: A novel iboga alkaloid congener having potential anti-addictive efficacy
21. 18-Methoxycoronaridine (18-MC) and ibogaine: Comparison of anti-addictive efficacy, toxicity and mechanisms of action
22. Neurobiological vulnerability to low-dose amphetamine psychosis
23. Activation of memory circuits during cue-elicited cocaine craving
24. Current concepts of addiction
25. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
26. Behavioral and neurochemical effects of acute and daily cocaine administration in rats
27. The pharmacology and neural circuitry of sensitization to psychostimulants
28. A role for sensitization in craving and relapse in cocaine addiction
29. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
30. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral response to the stereoisomers of amphetamine and methamphetamine
31. Subjective effects of oral caffeine in formerly cocaine-dependent humans
32. Rats pre-exposed to amphetamine will subsequently work more to obtain the drug and show enhanced DA overflow in the NAcc
33. Interactions between ibogaine and cocaine in rats: In vivo microdialysis and motor behavior
34. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine
35. Conditioning and experimental factors affecting the developments of sensitization to apomorphine
36. Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation
37. Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats
38. Pharmacology of ibogaine and ibogaine-related alkaloids
39. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
40. The neural basis of drug craving: An incentive-sensitization theory of drug addiction
41. Sensitization and tolerance in pyschostimulant self-administration
42. Repeated binge exposures to amphetamine and methamphetamine: Behavioral and neurochemical characterization
43. Animal models of stimulant-induced psychosis
44. Tolerance and sensitization to the behavioral effects of drugs
45. Ibogaine enhances the expression of cocaine-induced locomotor sensitization in chronic cocaine-treated animals
46. Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: A study with acute and chronic cocaine-treated rats
47. Iboga agents enhance the expression of cocaine-induced stereotypy in acute and chronic cocaine-treated rats
48. The potential anti-addictive agent, 18-methoxycoronaridine (18-MC) blocks the sensitized dopamine and locomotor responses produced by repeated morphine treatment
49. Differential effects of ibogaire on behavioural and dopamine sensitization
50. Interactions between 18-methoxycoronaridine (18-MC) and cocaine: Dissociation of behavioural and neurochemical sensitization
51. Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization
52. Rats pre-exposed to amphetamine in the ventral tegmental area, but not in the nucleus accumbens, will subsequently work more to obtain the drug
53. A psychomotor stimulant theory of addiction